Immunocore Holdings (IMCR) Equity Ratio (2019 - 2026)

Immunocore Holdings has disclosed Equity Ratio across 8 years of filings, most recently posting 0.37 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.37, changed 0.26% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.37 (changed 0.26% YoY), and the FY2025 annual result was 0.36, changed 0.08% from the prior year.
• Equity Ratio came in at 0.37 for Q1 2026 at Immunocore Holdings, up from 0.36 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.64 in Q4 2022 to a low of 0.35 in Q3 2024.
• The 5-year median for Equity Ratio is 0.36 (2025), against an average of 0.41.
• Across the five-year window, Equity Ratio increased 12.59% in 2022 and sank 42.17% in 2024, its largest moves.
• Immunocore Holdings' Equity Ratio stood at 0.64 in 2022, then retreated by 3.47% to 0.62 in 2023, then plunged by 42.17% to 0.36 in 2024, then slipped by 0.08% to 0.36 in 2025, then gained by 2.85% to 0.37 in 2026.
• The last three Equity Ratio figures came in at 0.37 (Q1 2026), 0.36 (Q4 2025), and 0.36 (Q3 2025), per Business Quant data.